We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Modified Ligand Helps Activate Cancer-Fighting T Cells

News   Apr 03, 2018 | Original story from the University of Connecticut

 
Modified Ligand Helps Activate Cancer-Fighting T Cells

This is an illustration showing interactions between components of the AH10-7 compound (yellow), an immune system antigen-presenting cell (gray), and an invariant natural killer T cell (green and blue) that spark activation of iNKT cells in 'humanized' mice. Credit: Jose Gascon/UConn

 
 
 

RELATED ARTICLES

Neutrons Paint Atomic Portrait of Protein Kinase A

News

Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis

READ MORE

Zika Study May "Supercharge" Vaccine Research

News

Scientists looking at the genetics of Zika virus have found a way to fast-track research which could lead to new vaccines.

READ MORE

Discovering the Parameters That Govern the Encapsulation of Drugs

News

Researchers at Eindhoven University of Technology and Utrecht University have discovered the parameters that govern the encapsulation of drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE